Quantitative 3D histochemistry reveals region-specific amyloid-β reduction by the antidiabetic drug netoglitazone
Open Access
- 6 May 2025
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (5) , e0309489
Abstract
A hallmark of Alzheimer’s disease (AD) is the extracellular aggregation of toxic amyloid-beta (Aβ) peptides in form of plaques. Here, we identify netoglitazone, an antidiabetic compound previously tested in humans, as an Aβ aggregation antagonist. Netoglitazone improved cognition and reduced microglia activity in a mouse model of AD. Using quantitative whole-brain three-dimensional histology (Q3D), we precisely identified brain regions where netoglitazone reduced the number and size of Aβ plaques. We demonstrate the utility of Q3D in preclinical drug evaluation for AD by providing a high-resolution brain-wide view of drug efficacy. Applying Q3D has the potential to improve pre-clinical drug evaluation by providing information that can help identify mechanisms leading to brain region-specific drug efficacy.Keywords
All Related Versions
Funding Information
- NOMIS Stiftung
- Fondazione Gelu
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (179040, 207872)
- Human Frontier Science Program (RGP0001/2022)
- Michael J. Fox Foundation for Parkinson's Research (MJFF-022156)
- DCoMEX
- NIH/NINDS (DP1 NS116783)
- NIH/NINDS (R01 AG064051)
- NIH/NINDS (R01 EB030884)
This publication has 110 references indexed in Scilit:
- Donanemab in Early Symptomatic Alzheimer DiseaseJAMA, 2023
- Therapeutic anti‐amyloid β antibodies cause neuronal disturbancesAlzheimer's & Dementia, 2022
- Liraglutide and semaglutide: Pooled post hoc analysis to evaluate risk of dementia in patients with type 2 diabetesAlzheimer's & Dementia, 2020
- Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019Alzheimer's & Dementia, 2020
- 2020 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2020
- BACE1 regulates the proliferation and cellular functions of Schwann cellsGlia, 2017
- Cortical asymmetry in Parkinson's disease: early susceptibility of the left hemisphereBrain and Behavior, 2016
- Amyloid-β and TauJAMA Neurology, 2014
- A Randomized Pilot Clinical Trial of the Safety of Pioglitazone in Treatment of Patients With Alzheimer DiseaseArchives of Neurology, 2011
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004